Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix K Chun

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Asian Journal of Andrology|September 27, 2017
Radical prostatectomy in patients aged 75 years or older: review of the literaturePhilipp Mandel, Thenappan Chandrasekar, Felix K Chun, et al.
World Journal of Urology|May 15, 2014
The role of biomarkers in the assessment of prostate cancer risk prior to prostate biopsy: which markers matter and how should they be used?Marianne Schmid, Quoc-Dien Trinh, Markus Graefen, et al.
European Urology|August 12, 2008
Sequential use of the tyrosine kinase inhibitors sorafenib and sunitinib in metastatic renal cell carcinoma: a retrospective outcome analysisChristian Eichelberg, Roman Heuer, Felix K Chun, et al.
The Canadian Journal of Urology|December 22, 2015
The ARTUS device: the first feasibility study in human cadaversTim A Ludwig, Philip Reiss, Marco Wieland, et al.
European Urology Focus|July 21, 2017
Smoking and Bladder Cancer: A Systematic Review of Risk and OutcomesMichael Rink, Joseph J Crivelli, Shahrokh F Shariat, et al.
European Urology Focus|July 28, 2018
Accuracy of <sup>68</sup>Ga-Prostate-specific Membrane Antigen Positron Emission Tomography for the Detection of Lymph Node Metastases Before Salvage LymphadenectomyPhilipp Mandel, Derya Tilki, Felix K Chun, et al.
European Urology|May 6, 2014
A "PSA pyramid" for men with initial prostate-specific antigen ≤3 ng/ml: a plea for individualized prostate cancer screeningMarco Randazzo, Josef Beatrice, Andreas Huber, et al.
World Journal of Urology|March 28, 2018
The impact of time to catheter removal on short-, intermediate- and long-term urinary continence after radical prostatectomyDerya Tilki, Felix Preisser, Pierre Karakiewicz, et al.
World Journal of Urology|April 3, 2019
Tumor characteristics, oncological and functional outcomes after radical prostatectomy in very young men ≤ 45 years of ageDerya Tilki, Valentin Maurer, Raisa S Pompe, et al.
World Journal of Urology|August 23, 2017
Long-term oncological outcomes in patients with limited nodal disease undergoing radical prostatectomy and pelvic lymph node dissection without adjuvant treatmentPhilipp Mandel, Clemens Rosenbaum, Raisa S Pompe, et al.
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Asian Journal of Andrology|September 27, 2017
Radical prostatectomy in patients aged 75 years or older: review of the literaturePhilipp Mandel, Thenappan Chandrasekar, Felix K Chun, et al.
World Journal of Urology|May 15, 2014
The role of biomarkers in the assessment of prostate cancer risk prior to prostate biopsy: which markers matter and how should they be used?Marianne Schmid, Quoc-Dien Trinh, Markus Graefen, et al.
European Urology|August 12, 2008
Sequential use of the tyrosine kinase inhibitors sorafenib and sunitinib in metastatic renal cell carcinoma: a retrospective outcome analysisChristian Eichelberg, Roman Heuer, Felix K Chun, et al.
The Canadian Journal of Urology|December 22, 2015
The ARTUS device: the first feasibility study in human cadaversTim A Ludwig, Philip Reiss, Marco Wieland, et al.
European Urology Focus|July 21, 2017
Smoking and Bladder Cancer: A Systematic Review of Risk and OutcomesMichael Rink, Joseph J Crivelli, Shahrokh F Shariat, et al.
European Urology Focus|July 28, 2018
Accuracy of <sup>68</sup>Ga-Prostate-specific Membrane Antigen Positron Emission Tomography for the Detection of Lymph Node Metastases Before Salvage LymphadenectomyPhilipp Mandel, Derya Tilki, Felix K Chun, et al.
European Urology|May 6, 2014
A "PSA pyramid" for men with initial prostate-specific antigen ≤3 ng/ml: a plea for individualized prostate cancer screeningMarco Randazzo, Josef Beatrice, Andreas Huber, et al.
World Journal of Urology|March 28, 2018
The impact of time to catheter removal on short-, intermediate- and long-term urinary continence after radical prostatectomyDerya Tilki, Felix Preisser, Pierre Karakiewicz, et al.
World Journal of Urology|April 3, 2019
Tumor characteristics, oncological and functional outcomes after radical prostatectomy in very young men ≤ 45 years of ageDerya Tilki, Valentin Maurer, Raisa S Pompe, et al.
World Journal of Urology|August 23, 2017
Long-term oncological outcomes in patients with limited nodal disease undergoing radical prostatectomy and pelvic lymph node dissection without adjuvant treatmentPhilipp Mandel, Clemens Rosenbaum, Raisa S Pompe, et al.
Pageof 7